# A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

> **NCT05025787** · PHASE2 · COMPLETED · sponsor: **Maurizio Fava, MD** · enrollment: 55 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** CNTX-6970
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05025787
- **Lead sponsor:** Maurizio Fava, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2024-06-11
- **Final completion:** 2024-06-11
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05025787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05025787, "A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05025787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*